<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene S477N;D614G literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.S477N;D614G</span> literature reference collection</h1>
<div class="effect_section"><h2 id="convalescent_plasma_binding">Convalescent plasma binding</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Lentiviral pseudotyped with the key mutations from 20A.EU2 lineage was neutralized slightly less than D614G in 10 convalescent sera from April 2020 infectees.<br/> (<a href="https://doi.org/10.1101/2021.02.05.430003" class="lit_link">Tada et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="reinfection">Reinfection</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> 11 cases of re-infection with the "Marseille-4" variant found within 1028 positive tests, where all of the earlier infections were from different strains.<br/>This lineage is also characterized by N:p.M234I;A376T (<a href="https://doi.org/10.1016/j.ijid.2021.03.068" class="lit_link">Fournier et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="symptom_prevalence">Symptom prevalence</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Compared to the clade 20A strains that predominated during phase 1 between March and May 2020, the Marseille-4 variant (characterized  by this mutation plus N:p.M234I;A376T) was associated with a lower frequency of cough, rhinitis, and olfactory and gustatory disorders.<br/>By contrast, hypoxemia was more frequent in patients infected with the Marseille-4 variant. (<a href="https://doi.org/10.1016/j.ijid.2021.03.068" class="lit_link">Fournier et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="trafficking">Trafficking</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Lentiviral pseudotyped with the key mutations from 20A.EU2 lineage was tested on ACE2.293T cells. Luciferase activity was measured two days postinfection,  showing no significant change in infection rate amongst the cells, suggesting that this  mutation does not contributing to cell entry fitness.<br/> (<a href="https://doi.org/10.1101/2021.02.05.430003" class="lit_link">Tada et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
